<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045350"><TermName>mafosfamide</TermName><TermPronunciation>(muh-FOS-fuh-mide)</TermPronunciation><TermDefinition><DefinitionText>A form of cyclophosphamide that can be administered as an intrathecal infusion. Mafosfamide is being studied as an anticancer drug. It belongs to the family of drugs called alkylating agents.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730900" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mafosfamide&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730901" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mafosfamida&quot;" language="es" id="_4"/><SpanishTermName>mafosfamida</SpanishTermName><SpanishTermDefinition><DefinitionText>Forma de la ciclofosfamida que se puede administrar como infusión intratecal. La mafosfamida está en estudio como medicamento contra el cáncer. Es un alquilante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
